Malaysia
Search
Sign In
Change Password
Points
Sign Out
Monitoring
Cervical Cancer Stage IA1
- Follow-up visit every 3-6 months x 2 years, then every 6-12 months x 3-5 years, then annually
- Cervical/vaginal cytologic exam annually as indicated
- Consider complete blood count (CBC), blood urea nitrogen (BUN), creatinine every 6 months or as indicated
- Imaging should be based on patient’s symptoms and concern for metastatic or recurrent disease
- Educate patient on potential recurrence symptoms, effects of treatment, periodic self-examinations, and sexual health (eg use of vaginal dilator, vaginal moisturizers/lubricants)
- Counsel patient on exercise, obesity, nutrition, lifestyle and smoking cessation
Cervical Cancer Stage IA2, IB1, IIA1
- Follow-up visit every 3-6 months x 2 years, then every 6-12 months x 3-5 years, then annually
- Cervical/vaginal cytologic exam annually as indicated
- Consider CBC, BUN, creatinine every 6 months or as indicated
- Imaging should be based on patient’s symptoms and concern for metastatic or recurrent disease
- Educate patient on potential recurrence symptoms, effects of treatment, periodic self-examinations, and sexual health (eg use of vaginal dilator, vaginal moisturizers/lubricants)
- Counsel patient on exercise, obesity, nutrition, lifestyle and smoking cessation
Cervical Cancer Stage IB2, IIA2, IIB, IIIA, IIIB, IVA
- Follow-up visit every 3-6 months x 2 years, then every 6-12 months x 3-5 years, then annually
- Cervical/vaginal cytologic exam annually as indicated
- Consider CBC, BUN, creatinine every 6 months or as indicated
- Imaging should be based on patient’s symptoms and concern for metastatic or recurrent disease
- At 3-6 months posttreatment completion, the following may be performed:
- Stage IB2: Whole body PET/CT
- Stage II-IV: Whole body PET/CT (preferred), CT with contrast of the chest, abdomen or pelvis, or MRI with contrast of the pelvis (optional)
- At 3-6 months posttreatment completion, the following may be performed:
- Educate patient on potential recurrence symptoms, effects of treatment, periodic self-examinations, and sexual health (eg use of vaginal dilator, vaginal moisturizers/lubricants)
- Counsel patient on exercise, obesity, nutrition, lifestyle and smoking cessation
Metastatic Cervical Cancer
- Follow-up visit every 3-6 months x 2 years, then every 6-12 months x 3-5 years, then annually
- Cervical/vaginal cytologic exam annually as indicated
- Consider CBC, BUN, creatinine every 6 months or as indicated
- Imaging should be based on patient’s symptoms and concern for metastatic or recurrent disease
- Educate patient on potential recurrence symptoms, effects of treatment, periodic self-examinations, and sexual health (eg use of vaginal dilator, vaginal moisturizers/lubricants)
- Counsel patient on exercise, obesity, nutrition, lifestyle and smoking cessation
.jpg)
